Clinical trial
Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a…
NCT00227422 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00227422 |
|---|---|
| Title | Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs |
| Official title | A Phase IV, Partially Double-blind Study to Demonstrate Non-inferiority of GSK Biologicals' Mencevax™ ACWY (New Process) Versus Mencevax™ ACWY (Current Process) When Administered as a Single Dose to Subjects Aged 2-30 Yrs |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infections, Meningococcal |
| Intervention type | Biological |
| Interventions | Mencevax ACWY |
| Enrollment | 324 |
| Start date | Jun 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 28, 2005 |
| Last update posted | Sep 21, 2016 |
| Countries | Lebanon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: